Previous Article | Next Article ![]()
Journal of Virology, August 2001, p. 7375-7383, Vol. 75, No. 16
Department of Microbiology, Mount Sinai
School of Medicine, New York University, New York, New York 10029
Received 23 January 2001/Accepted 16 May 2001
Nucleocytoplasmic transport of viral ribonucleoproteins (vRNPs) is
an essential aspect of the replication cycle for influenza A, B, and C
viruses. These viruses replicate and transcribe their genomes in the
nuclei of infected cells. During the late stages of infection, vRNPs
must be exported from the nucleus to the cytoplasm prior to transport
to viral assembly sites on the cellular plasma membrane. Previously, we
demonstrated that the influenza A virus nuclear export protein (NEP,
formerly referred to as the NS2 protein) mediates the export of vRNPs.
In this report, we suggest that for influenza B and C viruses the
nuclear export function is also performed by the orthologous NEP
proteins (formerly referred to as the NS2 protein). The influenza virus
B and C NEP proteins interact in the yeast two-hybrid assay with a
subset of nucleoporins and with the Crm1 nuclear export factor and can
functionally replace the effector domain from the human
immunodeficiency virus type 1 Rev protein. We established a plasmid
transfection system for the generation of virus-like particles (VLPs)
in which a functional viral RNA-like chloramphenicol acetyltransferase
(CAT) gene is delivered to a new cell. VLPs generated in the
absence of the influenza B virus NEP protein were unable to transfer
the viral RNA-like CAT gene to a new cell. From these data, we suggest
that the nuclear export of the influenza B and C vRNPs are mediated through interaction between NEP proteins and the cellular
nucleocytoplasmic export machinery.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.16.7375-7383.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Influenza B and C Virus NEP (NS2) Proteins
Possess Nuclear Export Activities


*
Corresponding author. Mailing address: Department of
Microbiology, Mount Sinai School of Medicine, New York University, 1 Gustave L. Levy Place, New York, NY 10029. Phone: (212) 241-7318. Fax:
(212) 722-3634. E-mail: peter.palese{at}mssm.edu.
Present address: Center for the Study of Hepatitis C, Department of
Virology and Infectious Disease, Rockefeller University, New York, NY 10021.
Present address: Wyeth Lederle Vaccines, Pearl River, NY 10965.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»